September 22, 2014 10:43 PM ET

Biotechnology

Company Overview of Applied Genetic Technologies Corporation

Company Overview

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops gene therapy products for inherited orphan ophthalmology diseases in the United States. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa, which are diseases of the eye caused by mutations in single genes. The company also completed preclinical proof-of-concept studies, and Phase I and Phase II clinical trials of a treatment for alpha-1 antitrypsin deficiency, an inherited orphan lung disease. In addition, it has proof-of-concept programs for other eye diseases, such as leber congenital amaurosis (type 2)...

11801 Research Drive

Suite D

Alachua, FL 32615

United States

Founded in 1999

14 Employees

Phone:

386-462-2204

Key Executives for Applied Genetic Technologies Corporation

Chief Executive Officer
Age: 52
Total Annual Compensation: $313.9K
Chief Financial Officer and Principal Accounting Officer
Age: 58
Total Annual Compensation: $175.0K
Chief Medical Officer and Vice President
Age: 67
Total Annual Compensation: $336.2K
Chief Business Officer and Vice President
Age: 54
Total Annual Compensation: $255.7K
Senior Director of Process Development
Age: 40
Total Annual Compensation: $122.4K
Compensation as of Fiscal Year 2014.

Applied Genetic Technologies Corporation Key Developments

Applied Genetic Technologies Corporation Presents at Citi's 9th Annual Biotech Conference, Sep-04-2014 12:15 PM

Applied Genetic Technologies Corporation Presents at Citi's 9th Annual Biotech Conference, Sep-04-2014 12:15 PM. Venue: The Mandarin Oriental Boston, 776 Boylston Street, Boston, MA 02119, United States. Speakers: Susan B. Washer, Chief Executive Officer, President and Director.

Applied Genetic Technologies Corporation Presents at Piper Jaffray Heartland Summit 2014, Aug-07-2014

Applied Genetic Technologies Corporation Presents at Piper Jaffray Heartland Summit 2014, Aug-07-2014 . Venue: Minneapolis, Minnesota, United States. Speakers: Sue Washer, President and CEO.

Applied Genetic Technologies Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-13-2014 01:20 PM

Applied Genetic Technologies Corporation Presents at Wedbush 2014 Life Sciences Management Access Conference, Aug-13-2014 01:20 PM. Venue: Le Parker Meridien, New York, New York, United States. Speakers: Sue Washer, President and CEO.

Similar Private Companies By Industry

Company Name Region
Padlock Therapeutics, Inc. United States
True North Therapeutics, Inc. United States
SironRX Therapeutics, Inc. United States
Metacine, Inc. United States
Apse LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 1, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Applied Genetic Technologies Corporation, please visit www.agtc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.